Mitrev N - Search Results

1

Review of exclusive enteral therapy in adult Crohn's disease.

Mitrev N, Huang H, Hannah B, Kariyawasam VC. Mitrev N, et al. BMJ Open Gastroenterol. 2021 Sep;8(1):e000745. doi: 10.1136/bmjgast-2021-000745. BMJ Open Gastroenterol. 2021. PMID: 34580154 Free PMC article. Review.

2

Medication non-adherence in inflammatory bowel diseases is associated with disability.

Perry J, Chen A, Kariyawasam V, Collins G, Choong C, Teh WL, Mitrev N, Kohler F, Leong RWL. Perry J, et al. Among authors: mitrev n. Intest Res. 2018 Oct;16(4):571-578. doi: 10.5217/ir.2018.00033. Epub 2018 Oct 10. Intest Res. 2018. PMID: 30301333 Free PMC article.

3

Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey.

Cheema M, Mitrev N, Hall L, Tiongson M, Ahlenstiel G, Kariyawasam V. Cheema M, et al. Among authors: mitrev n. BMJ Open Gastroenterol. 2021 Feb;8(1):e000581. doi: 10.1136/bmjgast-2020-000581. BMJ Open Gastroenterol. 2021. PMID: 33579729 Free PMC article.

4

Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis.

Kariyawasam VC, Mourad FH, Mitrev N, Paramsothy S, Selinger CP, Katelaris PH, Jones B, McDonald C, Barr G, Chapman G, Cowlishaw J, Andrews J, Leong RW. Kariyawasam VC, et al. Among authors: mitrev n. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(12):1524-1532. doi: 10.1097/MEG.0000000000002101. Eur J Gastroenterol Hepatol. 2021. PMID: 33731581

5

Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn's disease: A case report and review of literature.

Au M, Mitrev N, Leong RW, Kariyawasam V. Au M, et al. Among authors: mitrev n. World J Clin Cases. 2022 Mar 16;10(8):2569-2576. doi: 10.12998/wjcc.v10.i8.2569. World J Clin Cases. 2022. PMID: 35434082 Free PMC article.

6

Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study.

Huang D, Rennie M, Krasovec A, Nagubandi S, Liu S, Ge E, Khehra B, Au M, Sivagnanam S, Kwan V, Rogge C, Mitrev N, Kariyawasam V. Huang D, et al. Among authors: mitrev n. Ther Adv Chronic Dis. 2024 Mar 28;15:20406223241233203. doi: 10.1177/20406223241233203. eCollection 2024. Ther Adv Chronic Dis. 2024. PMID: 38560721 Free PMC article.

7

Treatment endpoints in ulcerative colitis: Does one size fit all?

Mitrev N, Kariyawasam V. Mitrev N, et al. World J Gastrointest Pharmacol Ther. 2024 May 5;15(2):91591. doi: 10.4292/wjgpt.v15.i2.91591. World J Gastrointest Pharmacol Ther. 2024. PMID: 38764502 Free PMC article.

8

On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease.

Karimi N, Moore AR, Jones A, Lukin A, Pipicella JL, Williams AJ, Ng W, Kanazaki R, Kariyawasam V, Mitrev N, Pandya K, Andrews JM, Connor SJ. Karimi N, et al. Among authors: mitrev n. Patient Educ Couns. 2025 Jan;130:108487. doi: 10.1016/j.pec.2024.108487. Epub 2024 Oct 28. Patient Educ Couns. 2025. PMID: 39500104 Free article.

9

Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease.

Mitrev N, Leong RW. Mitrev N, et al. Expert Opin Drug Saf. 2017 Mar;16(3):303-317. doi: 10.1080/14740338.2017.1269169. Epub 2016 Dec 22. Expert Opin Drug Saf. 2017. PMID: 27922765 Review.

10

Hygiene Hypothesis: Is the Evidence the Same All Over the World?

Leong RW, Mitrev N, Ko Y. Leong RW, et al. Among authors: mitrev n. Dig Dis. 2016;34(1-2):35-42. doi: 10.1159/000442922. Epub 2016 Mar 16. Dig Dis. 2016. PMID: 26982573 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters